|

Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction

RECRUITINGSponsored by Asfendiyarov Kazakh National Medical University
Actively Recruiting
SponsorAsfendiyarov Kazakh National Medical University
Started2025-03-03
Est. completion2026-01-01
Eligibility
Age18 Years – 69 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06953180

Summary

This study aims to enhance personalized and preventive care for non-communicable diseases (NCDs) in Kazakhstan by examining epigenetic factors, predicting biological age and reproductive function using machine learning, and developing health improvement recommendations.

Eligibility

Age: 18 Years – 69 YearsHealthy volunteers accepted
Inclusion Criteria:

* Adults aged 18 to 69 years.
* Residents of 17 regions of Kazakhstan.
* Willingness to participate and provide informed consent.

Exclusion Criteria:

* Age less than 18 years old or over 69 years old.
* Failure to provide informed consent or incomplete participation in data collection procedures.

Conditions6

Cardiovascular Diseases (CVD)Chronic Kidney DiseasesChronic Respiratory DiseasesDiabetesObesity (Disorder)Type 2 Diabetes

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.